News
Natera, Diakonos Oncology Pair to Test Molecular Response in Refractory Melanoma Patients
28+ min ago (363+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
Samsung Bioepis Launches OPUVIZ Biosimilar in Europe
2+ hour, 28+ min ago (170+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
Astra Zeneca's Imfinzi Approved by FDA for BCG-Na've Non-Muscle-Invasive Bladder Cancer
1+ hour, 25+ min ago (343+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
Pfizer, Innovent Strike $10. 5 Billion Oncology Deal to Develop 12 Cancer Medicines
3+ hour, 2+ min ago (192+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
3 Clinical Trial Rebound Trends " And How to Scale Smoothly
22+ hour, 46+ min ago (473+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
AI-Designed Drug Enters Phase I Trial
1+ day, 24+ min ago (252+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
Wu Xi Biologics Shanghai Drug Product Facility Achieves GMP Release
1+ day, 20+ hour ago (385+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
Delphia Therapeutics Names David Kerstein Chief Medical Officer
2+ day, 20+ hour ago (491+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
Samsung Bioepis Launches Ustekinumab Biosimilar in Japan
1+ week, 2+ day ago (176+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...
Astra Zeneca, Daiichi Sankyo's Enhertu Gets New US Approval for Two HER2-Positive Breast Cancer Indications
1+ week, 3+ day ago (330+ words) Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks. A video roundup of the week's top…...